This page includes the latest FDA filings for Xiamen L P Pharmaceutical Co L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Carwin Pharmaceutical Associates, LLC, Xiamen LP Pharmaceutical Co., Ltd. | Prescription Medication | 2024-11-07 |
Vitruvias Therapeutics, Inc. | Prescription Medication | 2024-02-19 |
Vitruvias Therapeutics, Inc. | Prescription Medication | 2023-12-15 |
Xiamen LP Pharmaceutical Co., Ltd. | Memantine Hydrochloride | 2022-10-21 |
Xiamen LP Pharmaceutical Co., Ltd. | Memantine Hydrochloride | 2022-10-21 |
Xiamen LP Pharmaceutical Co., Ltd. | Memantine Hydrochloride | 2022-10-21 |
Xiamen LP Pharmaceutical Co., Ltd. | Prescription Medication | 2022-10-21 |
Xiamen LP Pharmaceutical Co., Ltd. | Prescription Medication | 2021-06-17 |
Xiamen LP Pharmaceutical Co., Ltd. | Pramipexole Dihydrochloride | 2021-06-11 |
Xiamen LP Pharmaceutical Co., Ltd. | Pramipexole Dihydrochloride | 2021-06-11 |
Xiamen LP Pharmaceutical Co., Ltd. | Prescription Medication | 2020-10-28 |
Xiamen LP Pharmaceutical Co., Ltd. | Clonidine Hydrochloride | 2017-12-01 |
Xiamen LP Pharmaceutical Co., Ltd. | Prescription Medication | 2017-12-01 |